中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Epidemiology and Pathophysiology of Parkinsonism in the Caribbeans

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态招聘中
赞助商
Centre Hospitalier Universitaire de Pointe-a-Pitre

关键词

抽象

The primary aim of this study is to estimate the frequency and to characterize clinically atypical parkinsonism in the French West Indies and Guyana.

描述

An atypical akineto-rigid parkinsonian syndrome, unresponsive to L-dopa has been evidenced in Guadeloupe. Abnormally frequent, this progressive supranuclear palsy (PSP)-like syndrome represents a new clinical entity. Unlike in classical PSP 70% of patients have myoclonus, 59% hallucinations, 78% REM sleep behavior disorders. Oculomotor pattern differs from classical PSP suggesting that cortical dysfunction predominates over brainstem impairments. Neuropathological examination in four patients has shown a widespread accumulation of the tau protein in the basal ganglia, the midbrain and cortical areas.

This syndrome has been associated to the regular consumption of food products derived from plants of the Annonaceae family, more specifically Annona Muricata (soursop), suggesting a toxic origin. We have already confirmed the neurotoxic potential of the lipophilic mitochondrial complex I inhibitor annonacin, the major acetogenin in Annona muricata. This class of compounds is specific to Annonaceae. Nanomolar concentrations of annonacin induce the death of dopaminergic neurons in culture, by impairment of energy production. Chronic systemic intoxication of rats with annonacin causes neuronal damage in the same brain regions that are damaged in patients with atypical parkinsonism. These results greatly suggest that the consumption of annonacea might contribute to the pathogenesis of the disease. The H1 subhaplotype in tau gene associated with PSP in Caucasians did not confer risk for PSP-like atypical parkinsonism in Guadeloupe.

日期

最后验证: 10/31/2017
首次提交: 11/23/2017
提交的预估入学人数: 12/04/2017
首次发布: 12/10/2017
上次提交的更新: 12/04/2017
最近更新发布: 12/10/2017
实际学习开始日期: 08/02/2012
预计主要完成日期: 08/02/2018
预计完成日期: 08/02/2023

状况或疾病

Atypical Parkinsonism

干预/治疗

Other: Clinical and biological exam

-

手臂组

干预/治疗
Other: Patients
Parkinson's patient
Other: witnesses: without parkinson's disease
Subjects without parkinson's disease

资格标准

有资格学习的年龄 19 Years 至 19 Years
有资格学习的性别All
接受健康志愿者
标准

Inclusion Criteria:

- Pour les patients :

1. Patient ou tiers responsable ayant reçu une information sur l'étude et ayant signé le consentement éclairé

2. Patient âgé de plus de 18 ans

3. Patient consultant en neurologie ou en gériatrie pour symptomatologie parkinsonienne ou pour troubles cognitifs évocateurs d'une démence à corps de Lewy

4. Patient domicilié aux Antilles-Guyane

Pour les témoins :

5. Conjoint ou accompagnant ayant reçu une information sur l'étude et ayant signé le consentement éclairé

6. Personne âgée de plus de 18 ans

7. Personne ne présentant pas de pathologie d'allure neurodégénérative (Parkinson, démence notamment)

8. Personne domiciliée aux Antilles-Guyane

Exclusion Criteria:

Pour les patients :

1. Syndrome parkinsonien secondaire (post-traumatique, vasculaire, iatrogène, post encéphalitique)

2. Patient non affilié au régime de sécurité sociale

3. En cas de difficulté de suivi le patient sera exclu de l'étude longitudinale

Pour les témoins :

1. Personnes présentant des troubles cognitifs ou un syndrome parkinsonien diagnostiqué.

2. Patient non affilié au régime de sécurité sociale -

结果

主要结果指标

1. to estimate the frequency and to characterize clinically atypical parkinsonism in the French West Indies and Guyana [At the end of the Period of inclusion, around 5-6 years]

Collection of : administrative and socioeconomic data, medical consultation with video recording , recording oculomotor to the atypical

次要成果指标

1. to compare the proportion of atypical forms within parkinsonian syndromes; [At the end of the Period of inclusion, around 5-6 years]

Collection of : administrative and socioeconomic data, medical consultation with video recording , recording oculomotor to the atypical neuropsychological balance assessment , Clinical diagnostic criteria Compilation of functional indicators of motor and cognitive autonomy and Collection of intercurrent medical events Food and exposure questionnaire Neuropsychological assessment Recording of oculomotor movements and Post-mortem analysis biological collection (plasma, DNA, serum)

2. to characterize the entity "Parkinson-dementia complex" described in Guadeloupe ; to characterize the entity "Parkinson-dementia complex" described in Guadeloupe ; [Through study completion, an average of 11 years]

Compilation of functional indicators of motor and cognitive autonomy and Collection of intercurrent medical events. Collection of : administrative and socioeconomic data, medical consultation with video recording , recording oculomotor to the atypical neuropsychological balance assessment ,

3. to determine the natural history of typical and atypical forms of parkinsonism by following a cohort of the incident cases only; [Through study completion, an average of 11 years]

Neuropsychological assessment Food and exposure survey

4. to determine the implication of a toxic alimentary factor in the etiopathogenesis of atypical forms and compare the results in the 3 areas (Guadeloupe, Guyane, Martinique); [Through study completion, an average of 11 years]

Neuropsychological assessment Food and exposure survey

5. to determine the latency of cognitive decline in idiopathic Parkinson's disease in the 3 areas ; [Through study completion, an average of 11 years, post-mortem analysis after death if applicable]

Recording of oculomotor movements and Post-mortem analysis (sampling of blood and cutaneous biopsy to establish a collection of biological samples)

6. to constitute a biological collection (plasma, DNA, serum). [At the end of the Period of inclusion, around 5-6 years]

biological collection (plasma, DNA, serum)

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge